Search results
Jun 24, 2024 · Biocon is a leading biotech company that develops and manufactures biosimilars, generics, APIs and novel biologics. It has a global presence, a strong patent portfolio and a social responsibility agenda.
- About Us
Biocon is a global biopharmaceutical company committed to...
- Products
Biocon is addressing global medical needs through a...
- Businesses
Biocon’s business strategy of delivering affordable...
- Investors
Biocon is a unique global biopharmaceutical company changing...
- Careers
It’s a chance at Biocon to work alongside some of the...
- Responsibility
Biocon Foundation is committed to improving lives and...
- News
News - Biocon - India's largest biopharmaceutical company
- Key Therapeutic Areas
At Biocon, our focus is on the three key therapeutic areas –...
- About Us
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. [4] The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, [5] including the United States and Europe. [4]
Biocon Share Price: Find the latest news on Biocon Stock Price. Get all the information on Biocon with historic price charts for NSE / BSE.
- 345.40
- 15,265.11
- 345.70
- 4,460,873
Biocon is a biotechnology company that offers a range of products, including generics, biosimilars, branded formulations and novel biologics. It aims to meet unmet patient needs and provide affordable access to advanced therapies for chronic conditions such as diabetes, oncology and immunology.
Biocon Biologics has created a Center of Excellence (CoE) for insulins in Malaysia with end-to-end capabilities to manufacture a broad portfolio of regular, basal and rapid insulins.
Get the latest Biocon Ltd (BIOCON) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Biocon is a global leader in biosimilars, biologics and APIs for chronic diseases. It has a rich pipeline of products, including a breakthrough drug for CoViD-19, and a social responsibility to provide affordable healthcare solutions.